Archived articles

Covid-19 vaccine

Q+A
Yes, you should get a booster
Published Jan 11, 2022
From preventing COVID-19 altogether to lessening symptoms and transmission with breakthrough infections, there are several good reasons to get an mRNA booster ASAP
Q+A
Making sense of the messiness of omicron
Published Jan 10, 2022
In this Q+A, experts from the Johns Hopkins Bloomberg School of Public Health address some common questions and scenarios with what is known right now
Q+A
Without global vaccinations, further variants ahead
Published Dec 21, 2021
Vaccine experts Anna Durbin and William Moss explain how vaccination prevents viral mutation, discuss remaining barriers to global vaccine access
Coronavirus
COVID-19 continues to hound U.S. with new surge, new variant
Published Dec 21, 2021
As the pandemic's second year ends, the nation struggles to avoid a repeat of widespread lockdowns. But vaccinations continue to tame the impact—for now.
COVID-19 briefing
Omicron variant is likely everywhere, delta cases increasing
Published Dec 6, 2021
Delta remains dominant around the world while omicron emerges, though time will tell whether the new variant will challenge vaccine effectiveness
Data tracking
Tracker finds widespread discrepancies in school COVID-19 policies
Published Nov 22, 2021
Variation occurs not only between states but also within states as individual districts adopt policies at odds with state guidelines
COVID-19
Another COVID-19 winter?
Published Nov 19, 2021
The U.S. appears to be on the brink of a winter surge in COVID-19 cases, but Johns Hopkins experts offer hope that this winter will be better than the last
Coronavirus
COVID-19 experts' kids get the vax
Published Nov 11, 2021
Masked smiles, happy dances, and jumps for joy were tweeted out by JHU researchers, epidemiologists, and clinicians to capture the moment their young children got their first doses of the COVID-19 vaccine
COVID-19 briefing
Experts worry plateau in U.S. cases foretells winter spike
Published Nov 5, 2021
'There are some early signs that we're headed in the wrong direction,' Hopkins epidemiologist Jennifer Nuzzo says while stressing importance of vaccine uptake
Q+A
COVID vaccines have been OK'd for kids. Now what?
Published Nov 4, 2021
Emergency use authorization for Pfizer/BioNTech's vaccine is unlikely to lead to widespread vaccinations among the nation's 28 million 5- to 11-year-olds, Hopkins vaccine expert William Moss says